Today’s vendors now offer specific implant technology that can no longer be categorized into a single specific implant classification. For example, a cervical spacer used to be just a cervical spacer. Today, that cervical spacer may be cleared for use by the FDA and classified as either a:

  • Cervical Spacer or Cage (requiring supplemental fixation)
  • Cervical Stand-Alone Device – Cage

The two constructs above should have the same price; however, the cervical stand-alone assembly (Cage + Plate + Screws) pricing will be higher.  Ergo, negotiating contracts and pricing for complex implants such as these can be challenging.

Below is an example of a surgeon profile for anterior cervical fusions:

Where do you start?

Any cervical spacer or cage that is part of a stand-alone assembly should be priced as a standard cervical cage.

In this example, we will focus on cervical stand-alone devices.

Review your current pricing

  • Calculate your average cost for a cervical spacer and a stand-alone cervical assembled device
  • Determine which vendors have the biggest discrepancies from the average cost and perform a focused audit of that vendor

Research your technology:  Current vendor websites and literature may not present the spacer as having multiple uses

  • Request the surgical technique guide from the vendor
  • Review the surgical technique guide to assist in understanding how the technology is assembled

In Example 1 below, the vendor classified the cervical spacer as a stand-alone spacer at a cost of $1850. This hospital’s average price for a cervical spacer is $800. After researching this technology, the spacer may be used a cervical spacer or as a component in a stand-alone cervical assembly. In this case, the device was utilized as a traditional cervical spacer at a cost of more than double the hospital’s average price for like technology.  If the cervical spacer had been classified and priced correctly, the total cost of the hardware would have been $2,860 vs $3,910 – a difference of over $1000.

Example 1

How do you fix the pricing and classification issue?

  1. Review/research the vendor’s technology for cervical spacers & cervical stand-alone devices
  2. Determine pricing and classification for the assembled stand-alone device and cervical spacers and update the vendor’s pricing file.
  3. Prepare an addendum to the current agreement

In Example 2 below, this vendor’s stand-alone cervical device consists of a cervical spacer, plate, cover plate, and 4 screws. The hospital’s average cost for a cervical stand-alone assembly is $3100. The below example prices the cervical spacer at $800 (the hospital’s average price) and prices the remaining implants to total $3100.  The hospital swapped the price of the spacer/cage with the plate – the vendor remains at the original agreed upon price for the cervical stand-alone, but the hospital is able to adjust the cervical spacer price to their current average price of $800.

Example 2

This was a less complicated example; however, some vendors have stand-alone devices with multi-hole plates. For example, one spine vendor has 2-hole, 3-hole, and 4-hole plates used in their cervical stand-alone assemblies; therefore, the assembly consists of a cervical spacer, one of the aforementioned plates, and 2, 3, or 4 screws.   How do you price this assembly?  The assembled price would include the spacer, a 4-hole plate, and 4 screws – similar to the Example #2 table above at the average price of $3100. If the 2-hole or 3-hole plates were used in the assembly, then the cost of the plates would be $2920 and $3010, respectively.

Now that you have this all worked out, some vendors have cervical spacers with built-in plates that can only be used in a stand-along assembly.  Again, it pays to research and know your technologies. Is it realistic to know all of them? No, but on a case-by-case basis, you and your team can target more expensive vendor technologies and make a positive impact on your bottom-line.

For more information, please contact Kim Nilsson at KNilsson@AskPHC.com or 980-721-2637, or John Ossowski at JOssowski@AskPHC.com or 801-209-3304 or Andrew Arreola at AArreola@AskPHC.com or 480-510-7940.

Engaging surgeons to assist in contracting for their implants has long been a challenge for most hospitals. Historical feedback from surgeons ranges from “it’s not my problem” to “I’ll just take may cases across the street if I cannot use my vendor of choice.”   Presently, organizations may now offer surgeons co-management, value-based, and gainsharing arrangements, as well as other forms of contractual alignments with hospitals. These new business models have proven useful in bringing better balance to the surgeon-hospital relationships vs the traditional surgeon-vendor relationship.

So, how do you engage your surgeons?

Prior to meeting with the surgeons and before sending contracts to the vendor, collecting data to educate your surgeons on current pricing is a critical first step. Creating a surgeon implant profile provides a visualization of vendor selection, type of implant, and total case costs. Typically, this data is not available from a single source but is a custom-crafted database created from multiple hospital data sources.

Below is an example of a surgeon profile for anterior cervical fusions:

A surgeon implant profile should be as detailed as possible to accurately reflect the surgeon’s practice and product selection. In this example, data is pulled from three different data sources: Operating Room Information System (ORIS), Materials Management Information System (MMIS), and discharge data from finance. Having common data elements across your data, such as the patient account number, is critical.

You never get a second chance at a first impression. Reviewing the combined data for accuracy is the most important part of this process. If the data is not accurate, you will lose credibility instantly with the surgeons. Data should be audited for missing implants, waste, and incorrect pricing. Does the case look correct? Where do you look for data points? Post op notes can provide the implants used and confirm the procedure performed. The implant log in the ORIS can confirm quantity implanted and waste. Verifying the purchase order in MMIS can also confirm implants used, quantity, and price.

Meeting the surgeon is a Who/What/When/Where scenario.

“Who” typically consists of two people:

  1. The Project Lead – the person who has the best understanding of the data, implants, and procedures performed; and,
  2. The person who has the best relationship with the surgeons, which may not be the same person for each surgeon. For the initial meeting(s), you may require someone present from the C-Suite or a credible leader the surgeon trusts.

“What” are the goals for the initial meeting?

Communicate your purpose – “We are set to renew our implant contracts and want to ensure we understand your implant selection and preferences.”  Start with reviewing their profile and explaining the graphs. Sample questions to ask the surgeon include:

  • Does this accurately portray your product selection?
  • Do you plan to utilize any different technologies and/or procedures in the future?
  • Would you consider utilizing a less expensive comparable product from your vendor?
  • Would you switch to another vendor should your current vendor not participate in lowering costs?

You could also share the hospital’s target pricing along with your benchmark pricing so the surgeon can see how their technology currently compares.

“When” and “Where” and how often do you meet with the surgeon? The initial meeting should take no longer than 15-30 minutes and should be scheduled at the surgeons’ convenience – whether their office, before/after their cases, or another location.

Communication is key to a successful surgeon engagement. Consistently following up with surgeons goes a long way in establishing positive ongoing relationships. Providing surgeon implant profiles on a monthly/quarterly basis keeps the surgeons engaged and willing to participate in current CVAT projects and assist future contracting efforts.

For more information, please contact Kim Nilsson at KNilsson@AskPHC.com or 980-721-2637, or John Ossowski at JOssowski@AskPHC.com or 801-209-3304 or Andrew Arreola at AArreola@AskPHC.com or 480-510-7940.

The Pinnacle Real Estate Group consists of a combination of professionals who use their extensive experience in both valuation and transaction services within the healthcare real estate industry to guide clients through multiple types of arrangements in a time-efficient and cost-effective manner.

This Newsletter covers recent activity and conditions specifically impacting the national healthcare real estate market and those who are learning how to succeed in it.  The Pinnacle Real Estate Group has compiled the following current market information from sources such as CoStar, CBRE, and HREI.

Healthcare Real Estate Transactions

$10.75 Million MOB acquired in Cleveland Suburb

Joint venture (JV) partners Remedy Medical Properties and Kayne Anderson Real Estate announced they have acquired the 34,519-square-foot Atrium of Brunswick in the Cleveland suburb of Brunswick, OH. The $10.75 million transaction closed August 23. The two-story medical office building (MOB), located at 1299 Industrial Parkway N., is 100 percent occupied by two tenants, including One GI, a gastroenterology group that recently acquired the building’s original tenant and seller Digestive Disease Consultants (DDC). The MOB also houses MetroHealth, which operates four hospitals and other healthcare facilities throughout the Cleveland area. MetroHealth operates a primary care and pediatrics practice at the MOB with rotating specialties including dermatology, rheumatology and sleep medicine.

$15.9 Million Sale of a 51,357 SF Medical Property in Geneseo, NY

SRS Real Estate Partners’ National Net Lease Group (NNLG) announced completion of the $15.9 million sale of a 51,357-square-foot (sf) medical property fully occupied by Rochester Regional Health – Geneseo Medical Campus. Built in 2021 and situated on 6.24 acres at 4302 Gateway Drive in Geneseo, NY, the property has more than 19 years remaining on the corporate-guaranteed lease. Rochester Regional Health is an integrated health system which includes nine hospitals, hundreds of outpatient specialty, urgent care, and primary practices. Its highly upgraded, state-of-the-art Geneseo property features a variety of highly specialized services including cardiology, radiology, endocrinology, orthopedics, dermatology, and general surgery. The property is part of the first phase in a multi-phase development plan on 26 acres that will include retail, office, and hospitality uses.

$37 Million Sale of Skilled Nursing Homes in Florida

Nursing home investor Omega Healthcare sold two Florida facilities in Miami and Jacksonville for a combined $37.2 million in the company’s latest asset disposition. Omega sold the skilled nursing facilities to 1990 South Canal Dr LLC, based in Woodmere, Long Island, New York, according to public documents. Each property was sold for $18.6 million, and Omega collected a profit on both sales.

Healthcare Real Estate New Construction

Los Angeles Approves 12-Story, Class-A Medical Building

Stockdale Capital Partners (“Stockdale”), a Los Angeles-based, vertically-integrated real estate investment firm, won approval from the Los Angeles City Council for its 145,000 square-foot, Class-A medical building on Los Angeles’ Westside, adjacent to the City of Beverly Hills at the intersection of San Vicente and Wilshire Boulevards.  Located near major health care facilities including Cedars-Sinai Medical Center, UCLA Medical Center, and numerous other medical specialists’ offices in the area, 656 S. San Vicente Blvd. is the first major outpatient medical office building built in the area in over twenty years, meeting pent-up demand by healthcare systems and physicians in the area with an extremely low vacancy rate of 5% or less since the Beverly Hills medical office moratorium was enacted in 2011. 656 S. San Vicente Blvd. is designed to accommodate modern, higher-acuity procedures such as surgery and other invasive outpatient services that are not easily-placed in the older building stock of the West Los Angeles office markets. In addition to modern, patient centered medical space, 656 will also be home to state-of-the-art laboratory space that will serve the needs of medical researchers and focused studies in a supply-constrained market for both medical office and life science.

Pinnacle Real Estate Group Assessment

MOB Sales Drop for Second Consecutive Quarter Confirming a Bubble in Activity

As indicated in our previous newsletter, the estimated MOB Sales numbers for Q2 2022 were $3.6B, which was considered strong and above recent historical average but significantly lower than the previous six quarters.  That downward trend has continued with the estimated MOB Sales numbers for Q2 2023 estimated at $2.6B, which is the lowest quarterly total since $2.1B posted in Q1 2021. This trend is predictable and probably necessary understanding the consistent rate hikes The Fed has made over this 2022 calendar year, with the latest being the first week of November, combined with many other active factors. Because of this trend the CAP Rates for MOB Sales have started to increase from 5.25% at the beginning of 2022 to now in the 6.15% range at the end of the Q3. Over the past two years, these MOB Sales numbers have confirmed a bubble in activity.  However, unlike bubbles in other markets, there need not be panic or fear of a crash.  Essentially, for the MOB Sales market it took advantage of multiple opportunistic factors and is now stabilizing back to a sustainable range.  We believe this sustainable range will continue for the foreseeable future.

For more information, please contact:

Mike Vandaveer, Director

720-599-7883

MVandaveer@AskPHC.com

Chris Louis, ASA, MAI, Director

720-598-1439

CLouis@AskPHC.com

Tony Price, Analyst

720-386-3540

TPrice@AskPHC.com

 

 

The Pinnacle Real Estate Group consists of a combination of professionals who use their extensive experience in both valuation and transaction services within the healthcare real estate industry to guide clients through multiple types of arrangements in a time-efficient and cost-effective manner.

This Newsletter covers recent activity and conditions specifically impacting the national healthcare real estate market and those who are learning how to succeed in it.  The Pinnacle Real Estate Group has compiled the following current market information from sources such as CoStar, CBRE, and HREI.

Healthcare Real Estate Transactions

$10.75 Million MOB acquired in Cleveland Suburb

Joint venture (JV) partners Remedy Medical Properties and Kayne Anderson Real Estate announced they have acquired the 34,519-square-foot Atrium of Brunswick in the Cleveland suburb of Brunswick, OH. The $10.75 million transaction closed August 23. The two-story medical office building (MOB), located at 1299 Industrial Parkway N., is 100 percent occupied by two tenants, including One GI, a gastroenterology group that recently acquired the building’s original tenant and seller Digestive Disease Consultants (DDC). The MOB also houses MetroHealth, which operates four hospitals and other healthcare facilities throughout the Cleveland area. MetroHealth operates a primary care and pediatrics practice at the MOB with rotating specialties including dermatology, rheumatology and sleep medicine.

$15.9 Million Sale of a 51,357 SF Medical Property in Geneseo, NY

SRS Real Estate Partners’ National Net Lease Group (NNLG) announced completion of the $15.9 million sale of a 51,357-square-foot (sf) medical property fully occupied by Rochester Regional Health – Geneseo Medical Campus. Built in 2021 and situated on 6.24 acres at 4302 Gateway Drive in Geneseo, NY, the property has more than 19 years remaining on the corporate-guaranteed lease. Rochester Regional Health is an integrated health system which includes nine hospitals, hundreds of outpatient specialty, urgent care, and primary practices. Its highly upgraded, state-of-the-art Geneseo property features a variety of highly specialized services including cardiology, radiology, endocrinology, orthopedics, dermatology, and general surgery. The property is part of the first phase in a multi-phase development plan on 26 acres that will include retail, office, and hospitality uses.

$37 Million Sale of Skilled Nursing Homes in Florida

Nursing home investor Omega Healthcare sold two Florida facilities in Miami and Jacksonville for a combined $37.2 million in the company’s latest asset disposition. Omega sold the skilled nursing facilities to 1990 South Canal Dr LLC, based in Woodmere, Long Island, New York, according to public documents. Each property was sold for $18.6 million, and Omega collected a profit on both sales.

Healthcare Real Estate New Construction

Los Angeles Approves 12-Story, Class-A Medical Building

Stockdale Capital Partners (“Stockdale”), a Los Angeles-based, vertically-integrated real estate investment firm, won approval from the Los Angeles City Council for its 145,000 square-foot, Class-A medical building on Los Angeles’ Westside, adjacent to the City of Beverly Hills at the intersection of San Vicente and Wilshire Boulevards.  Located near major health care facilities including Cedars-Sinai Medical Center, UCLA Medical Center, and numerous other medical specialists’ offices in the area, 656 S. San Vicente Blvd. is the first major outpatient medical office building built in the area in over twenty years, meeting pent-up demand by healthcare systems and physicians in the area with an extremely low vacancy rate of 5% or less since the Beverly Hills medical office moratorium was enacted in 2011. 656 S. San Vicente Blvd. is designed to accommodate modern, higher-acuity procedures such as surgery and other invasive outpatient services that are not easily-placed in the older building stock of the West Los Angeles office markets. In addition to modern, patient centered medical space, 656 will also be home to state-of-the-art laboratory space that will serve the needs of medical researchers and focused studies in a supply-constrained market for both medical office and life science.

Pinnacle Real Estate Group Assessment

MOB Sales Drop for Second Consecutive Quarter Confirming a Bubble in Activity

As indicated in our previous newsletter, the estimated MOB Sales numbers for Q2 2022 were $3.6B, which was considered strong and above recent historical average but significantly lower than the previous six quarters.  That downward trend has continued with the estimated MOB Sales numbers for Q2 2023 estimated at $2.6B, which is the lowest quarterly total since $2.1B posted in Q1 2021. This trend is predictable and probably necessary understanding the consistent rate hikes The Fed has made over this 2022 calendar year, with the latest being the first week of November, combined with many other active factors. Because of this trend the CAP Rates for MOB Sales have started to increase from 5.25% at the beginning of 2022 to now in the 6.15% range at the end of the Q3. Over the past two years, these MOB Sales numbers have confirmed a bubble in activity.  However, unlike bubbles in other markets, there need not be panic or fear of a crash.  Essentially, for the MOB Sales market it took advantage of multiple opportunistic factors and is now stabilizing back to a sustainable range.  We believe this sustainable range will continue for the foreseeable future.

For more information, please contact:

Mike Vandaveer, Director

720-599-7883

MVandaveer@AskPHC.com

Chris Louis, ASA, MAI, Director

720-598-1439

CLouis@AskPHC.com

Tony Price, Analyst

720-386-3540

TPrice@AskPHC.com

The Pinnacle Real Estate Group consists of a combination of professionals who use their extensive experience in both valuation and transaction services within the healthcare real estate industry to guide clients through multiple types of arrangements in a time-efficient and cost-effective manner.

This Newsletter covers recent activity and conditions specifically impacting the national healthcare real estate market and those who are learning how to succeed in it.  The Pinnacle Real Estate Group has compiled the following current market information from sources such as CoStar, CBRE, and HREI.

Healthcare Real Estate Transactions

Amazon’s Latest Deal Marks $3.9 Billion Bet on Brick-and-Mortar Healthcare

Amazon agreed to buy 1Life Healthcare establishing the online retail giant in the healthcare industry with a plan to disrupt it. One Medical, owned by 1Life, has 188 primary care facilities that provide virtual and in-office services, and competes with another Amazon experiment. This deal gives Amazon a turnkey entry into part of the healthcare market valued at upwards of $300 billion. However, it also opens the tech giant to risk as it acquires a not-yet-profitable firm in a highly competitive industry. This is not Amazon’s first move into healthcare,  acquiring online pharmacy PillPack in 2018 and the healthcare startup HealthNavigator in 2019. Last year, Amazon expanded its in-house Amazon Care program to its employees nationwide, immediately drawing comparisons to Amazon’s 2017 purchase of Whole Foods – its $13 billion entry into customer-facing brick-and-mortar operations. Similarly, we saw Amazon purchase an up-and-running brand with hopes that its tech and management expertise could disrupt a new sector. Now, it’s a waiting game to see how Amazon’s perseverance in the healthcare industry compares to that of the grocery sector. One Medical has operations in 25 markets across the country and described its physical locations as “well-appointed” in federal filings. The company claims 767,000 members, a number it conceded in its most recent quarterly report would need to grow to achieve profitability. It recorded a $254.6 million loss in 2021.

Abbott Laboratories Life Science Campus in Minneapolis Trades Hands

JLL Capital Markets, working alongside CBRE, announced it has closed the sale of Abbott Laboratories Life Science Campus, a four building, 280,289-square-foot life science portfolio in Minneapolis, Minnesota.  JLL and CBRE co-marketed the property on behalf of the seller, a joint venture between Eagle Ridge Partners and Syndicated Equities. Virtus Real Estate Capital (“Virtus”) acquired the portfolio. Abbott Laboratories Life Science Campus is fully leased to A+ investment grade credit tenant, Abbott Laboratories. The portfolio contains cGMP (“Current Good Manufacturing”) certified clean room, lab, and manufacturing space, as well as office and warehouse space. Across the four buildings located on 19.13 acres in the southwest submarket, there are 26 dock doors, 7 drive-ins, clear heights of 12-18 feet, and 640 parking spaces. Abbott Laboratories Life Science Campus has convenient access to the area’s vast transit system, including the Light Rail Transit system, regional freeways, and the Minneapolis-St. Paul International Airport.

Healthcare Real Estate New Construction

Vanderbilt Plans $500 Million Expansion of Nashville Hospital

Vanderbilt University Medical Center plans to build a $500 million medical tower at the primary hospital in Nashville, TN. The new building will be designed to serve as an inpatient facility with an expected completion date in 2027. The tower will be constructed above a parking deck between 21st Avenue South and Medical Center Drive. The new tower will provide 180 new beds whereas the current facility has been consistently strained, operating at more than 90% capacity. The 470,000 square foot structure will be connected to the main hospital building by multiple pedestrian bridges over existing streets. Another building on the campus will be demolished as a step in the process. VUMC is independent from the 14,000-student university but maintains an academic affiliation with its medical school. Vanderbilt Health System serves patients in middle Tennessee, northern Alabama, and portions of Kentucky. In addition to its Nashville hospital, the system also operates clinics in suburban and rural areas.

Pinnacle Real Estate Group Assessment

Healthcare Real Estate Remains an Attractive Option Despite MOB Sales Drop In 2nd Quarter

The healthcare real estate industry, specifically MOB Sales, broke records the previous four quarters cumulatively, with Q4 2021 being the highest ever recorded at $7.3B.  In the past few years, the quarterly average is in the $3B range with Q3 2021 at $5.7B, Q4 at $7.3B, and Q1 2022 at $4.6B.  The preliminary numbers for Q2 2022 are $3.6B, which is still considered strong and above recent historical averages.  However, it does indicate things seem to be coming back to “normal” with the excess of capital that flooded multiple market sectors – which is understandable and somewhat expected due to current inflation, multiple recent interest rate hikes, and what seems to be the conclusion of the financial reaction to the pandemic from the past two years.  Other market statistics for healthcare real estate remain strong: occupancy rates remain stable around 92%, and rental rates continue an upward trend with the national average around $23.72 per square foot with an annual increase close to two percent (2%).  However, in addition to a drop in MOB sales, there is an expected drop in new construction starts which are expected to continue trending moving forward while the current volatility in the market remains.  It seems the white-hot trends for healthcare real estate the past twelve to eighteen months peaked after Q1 2022 and will stabilize for the foreseeable future while remaining an attractive option for investors.

For more information, please contact:

Mike Vandaveer, Director

720-599-7883

MVandaveer@AskPHC.com

Chris Louis, ASA, MAI, Director

720-598-1439

CLouis@AskPHC.com

Tony Price, Analyst

720-386-3540

TPrice@AskPHC.com

PHC 1st Quarter 2022 Real Estate Newsletter

The Pinnacle Real Estate Group consists of a combination of professionals who use their extensive experience in both valuation and transaction services within the healthcare real estate industry to guide clients through multiple types of arrangements in a time-efficient and cost-effective manner.

This Newsletter covers recent activity and conditions specifically impacting the national healthcare real estate market and those who are learning how to succeed in it.  The Pinnacle Real Estate Group has compiled the following current market information from sources such as CoStar, CBRE, and HREI.

Healthcare Real Estate Transactions and New Construction

Life Science Firm, Seagan, Plans for 270,000 Square Foot Facility in Everett, Washington

The new facility which Seagan will commit to a long term lease is scheduled to be completed in 2024 and will office approximately 200 works will be focused on manufacturing the company’s cancer treatment medicines. The Seattle area is on of the nation’s 12 largest biotech clusters where the pipeline of life science projects has reached approximately 25 million square feet.

Montecito Medical Acquires MOB in Hazelton, Pennsylvania

The 73,255 square foot, multi-tenant, two story building is 100% leased to Lehigh Valley Health Network.  The building includes a 13,500 square foot ASC.  The purchase price was not disclosed but believed to be approximately $29.2M in a transaction where Montecito partnered with AEW Capital Management.

PMB & Dignity Health Break Ground on a 45,000 SF MOB in Gilbert, Arizona

The two story project is the third MOB located near the Dignity Health Mercy Gilbert Medical Center developed by PMB.  The new facility is scheduled to be completed in 2023 will include Dignity Health East Valley’s graduate medical program and supporting imagining services via Arizon Diagnostic Radiology.  The building is designed in a cost-effectie manner to ensure rents are close to market.

A $650M Business Investment Project For Development of a 500,000 Square Foot Biomanufacturing Facility in Manhattan, Kansas

Governor Laura Kelly announced her administration’s most significant economic development project to date. Scorpion Biological Services, a subsidiary of Heat Biologics, Inc., is commencing on a planned development of a new 500,000 square foot biomanufacturing facility in Kansas. The $650 million business investment project will create 500 new, high-paying jobs in Manhattan within the next seven years and support the development of vaccines.

Healthcare Real Estate Trends

MOB Sales: Estimated more than $3.8B in Q1 2022 concludes highest 12-month total

The first quarter of 2021 for MOB Sales was not impressive with a $2.1B total.  However, the final total for 2021 was $18.3B which is 15.3% higher than the next highest total confirmed by Revista ($15.5B in 2017).  The first quarter of 2022 has continued that path with preliminary numbers indicating a volume of $3.8B, which is up 90% form first quarter 2021 and the second highest first quarter MOB sales recorded by Revista since the record of first quarter 2017 ($3.9B).  This strong start to 2022 has totaled more than $20B in the past 12 months, which is the largest volume recorded by Revista for such a timeframe.

Pinnacle Real Estate Group Assessment

The Second Quarter 2022 Likely to Continue on its Impressive Path

The healthcare real estate industry for First Quarter 2022 continued on the unprecedented momentum generated in the past three quarters.  With the current reality of inflation, the ongoing issues with global supply chain issues, the war in Ukraine, combined with the First Quarter 2022 of the overall economy showing signs of a looming recession the healthcare real estate industry continues to show resiliency and maintain on its impressive path.  In the past few months, the sector of healthcare real estate that has firmly grabbed the baton and is clearly leading the industry are Life Sciences, or sometimes referred to as BioTech.  Life Sciences Real Estate (LSRE) is generating its own momentum and demanding attention throughout the entire healthcare real estate industry.  Life Sciences involves the study of living organisms: biology, botany, zoology, microbiology, and other related subjects such as biotechnology, pharmaceuticals, medical devices and therapeutics.  LSRE facilities will typically involve a combination of office, lab, and Research and Development (R&D).  Venture capital funding in U.S. life sciences has grown 328 percent during the last five years which included $32.5 billion in 2021.  There is currently 172.5 million square feet of LSRE in the U.S. with a current vacancy rate of 4.8% that raised average annual rental rate to $67.05 per square foot and cultivated 31.6 million square feet of new construction projects.  Investments in LSRE reach $21.4 billion in 2021, which is 62% increase from 2020.  We believe LSRE will aggressively continue on this path for the foreseeable future and continue to lead healthcare real estate on its impressive trend.

 

For more information, please contact:

Mike Vandaveer, Director

720-599-7883

MVandaveer@AskPHC.com

 

Chris Louis, ASA, MAI, Director

720-598-1439

CLouis@AskPHC.com

 

Tony Price, Analyst

720-386-3540

TPrice@AskPHC.com

PHC January 2022 Real Estate Newsletter

The Pinnacle Real Estate Group consists of a combination of professionals who use their extensive experience in both valuation and transaction services within the healthcare real estate industry to guide clients through multiple types of arrangements in a time-efficient and cost-effective manner.

This Newsletter covers recent activity and conditions specifically impacting the national healthcare real estate market and those who are learning how to succeed in it.  The Pinnacle Real Estate Group has compiled the following current market information from sources such as CoStar, CBRE, and HREI.

Healthcare Real Estate Transactions and New Construction

National Real Estate Advisors and Catalyst Healthcare Real Estate Invest $420 Million Across Two Portfolios

National Real Estate Advisors, LLC (“National”), an investment manager developing and managing large-scale projects on behalf of its clients, through its recently formed joint venture with Catalyst Healthcare Real Estate (“Catalyst”), has completed the acquisition and recapitalization of two multi-state healthcare portfolios totaling $420 million. The portfolios consist of 40 properties totaling 1.2 million square feet, spanning 13 states including: Alabama, Arkansas, Connecticut, Florida, Georgia, Illinois, Indiana, Louisiana, Massachusetts, North Carolina, Tennessee, Texas, and Virginia. The portfolios are 92% leased and 88% of the total leased space is comprised of health systems and regional physician groups.

Newmark Completes $815 Million Sale of Charles Park in Cambridge, Massachusetts

Newmark announces the $815 million sale of Charles Park, a two-building office complex and associated parking garage located in Cambridge, Massachusetts. The 408,259-square-foot Charles Park comprises two Class A office buildings—One Rogers Street and One Charles Park—complemented by a 656-space, seven-level parking garage. It features reusable in-place infrastructure for life science development, including large floor plates that can provide up to 65,000 square feet of contiguous space on one level, 13′ to 17′ ceiling heights and substantial loading capacity with five loading docks and two freight elevators.

Regency Sells San Diego Retail Property Ahead of Planned Conversion to Biotech Space

Regency Centers Corp. has sold a large San Diego retail property to biotech-focused Alexandria Real Estate Equities for $125 million, ahead of the buyer’s planned conversion of the site into a mixed-use development emphasizing the high demand for life sciences offices and laboratories. The 33-year-old Costa Verde Center, spanning about 178,000 square feet at 8508-8650 Genesee Ave. in the city’s University Town Center neighborhood was sold “for the proposed development of office/laboratory space.”

Healthcare Real Estate Trends

Biotech Construction not Keeping Pace with Rapidly Rising Nationwide Demand

Escalating demand for new life science laboratory space is outpacing speculative construction in one of the nation’s fastest-growing types of commercial real estate. A new report from brokerage CBRE points to several cities where the amount of speculative lab space under construction trails demand from companies scouting those regions for life science space. While about 21 million square feet of biotech space is under construction in the nation’s 12 largest life sciences markets, tenants are in the market for 23.8 million square feet. Much of this activity was underway before the pandemic, and the push for coronavirus vaccines and treatments has ramped up the flow of venture and government funding, spurring biotech firm expansion. Developers in the biggest biotech hubs are finding much of their speculative space preleased long before expected project completion dates.

Pinnacle Real Estate Group Assessment

The healthcare real estate industry for Calendar Year 2021 exceeded most expectations, broke records, and generated an unprecedented amount of momentum.  For varying reasons, primarily caused by reactions to the pandemic, the healthcare industry positioned itself as a stable, well performing, and attractive investment asset that in some aspects in a relatively quick amount of time leapfrogged over traditional retail and office properties from the perspective of large institutional investors.  We believe this trend will continue for Calendar Year 2022 for numerous reasons including the surge created within the past nine plus months will simply perpetuate through a majority of this year without much resistance.  However, the question that some are considering is when will the known obstacles begin to slow down the momentum built. The primary looming obstacle is inflation, which to some seems like it should have already occurred at this point, and it is more a matter of when than if.  Another obstacle that has surfaced the past year and will likely cause issues on a variety of levels and within numerous industries going forward, including healthcare real estate, are global supply chain issues which will directly impact timing and costs associated with new development construction projects as well as inventory of goods and supplies.  Overall, we expect healthcare real estate to continue its success but like other industries there will be obstacles to consider for Calendar Year 2022.

 

For more information, please contact:

Mike Vandaveer, Director

720-599-7883

MVandaveer@AskPHC.com

 

Chris Louis, ASA, MAI, Director

720-598-1439

CLouis@AskPHC.com

 

Tony Price, Analyst

720-386-3540

TPrice@AskPHC.com